BCR-ABL is a type of protein known as a tyrosine kinase. Drugs known as tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the most common treatment for CML. These drugs seem to work best when ...

Researchers at Mass General Brigham have found that an already-approved medication — a pain reliever and anti-seizure medication called gabapentin — has been linked to improved survival in ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

Here's how to sort out your symptoms and consider your treatment options. When Michelle Rockwell started struggling with sleep, perimenopause was not the first thing her primary care doctor suspected.

There was a roughly 10% annual reduction in the risk of developing Alzheimer's disease in people taking NRTIs for every year of use of these drugs, according to lead study author Dr. Jayakrishna ...

Instead, KJ has made medical history. The baby, now 9 ½ months old, became the first patient of any age to have a custom gene-editing treatment, according to his doctors. He received an infusion ...

Mark Cuban started his low-cost online pharmacy, Cost Plus Drugs, in 2022. Cuban said he started looking into the pharmaceutical business in 2017. He was prompted by friends in the GOP who asked ...

So how could this new order affect your healthcare? Here are seven expensive medications that could see a major drop in price this summer. While President Trump hasn’t mentioned any specific drugs by ...

sheffield.ac.uk Background: Persistent bacterial bronchitis (PBB) seems to be under-recognised ... wet cough for >1 month that resolves with appropriate antibiotic treatment. Conclusion: PBB is often ...

Your cup of coffee has health benefits, but it also interacts with some medications. Coffee may affect how a medication is absorbed, metabolized or removed from the body. An expert shares the ...

These laws are generally intended to make it easier for terminally ill people to access drugs in development not yet approved by the Food and Drug Administration. But Montana’s revision made it ...

And I'm here today to tell you some very exciting news. The American College of Rheumatology has just released the 2025 new guidelines on the treatment of systemic lupus. We could not be happier to ...